Table 5.
Association of L1CAM level with EJA patients' clinicopathologic features
| Variables | L1CAM protein | |||
|---|---|---|---|---|
| All cases | Low level | High level | P | |
| Age | ||||
| >63 | 44 | 31 | 13 | 0.226 |
| ≤63 | 15 | 8 | 7 | |
| Gender | ||||
| Male | 45 | 28 | 17 | 0.259 |
| Female | 14 | 11 | 3 | |
| Smoke | ||||
| Yes | 13 | 7 | 6 | 0.231 |
| No | 42 | 28 | 14 | |
| Unknown | 4 | 4 | 0 | |
| Diabetes | ||||
| Yes | 3 | 1 | 2 | 0.174 |
| No | 52 | 34 | 18 | |
| Unknown | 4 | 4 | 0 | |
| Adjuvant therapy | ||||
| Yes | 23 | 15 | 8 | 0.962 |
| No | 25 | 17 | 8 | |
| Unknown | 11 | 7 | 4 | |
| Depth of tumor invasion | ||||
| Tis | 2 | 2 | 0 | 0.454 |
| T1+T2 | 5 | 2 | 3 | |
| T3+T4 | 42 | 28 | 14 | |
| Unknown | 10 | 7 | 3 | |
| Lymph node metastasis | ||||
| N0 | 14 | 10 | 4 | 0.95 |
| N1 | 8 | 5 | 3 | |
| N2 | 7 | 5 | 2 | |
| N3 | 20 | 12 | 8 | |
| Unknown | 10 | 7 | 3 | |
| Distant metastasis | ||||
| Yes | 14 | 9 | 5 | 0.956 |
| No | 35 | 23 | 12 | |
| Unknown | 10 | 7 | 3 | |
| TNM stage | ||||
| Early stage (0+I+II) | 13 | 9 | 4 | 0.903 |
| Advanced stage (III+IV) | 36 | 23 | 13 | |
| Unknown | 10 | 7 | 3 | |
Comparisons between groups were conducted with the use of person's Chi² tests. EJA: esophagogastric junction adenocarcinomas.